Clinical Trial

Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia

Name: Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia — clinical trial record (NCT07075237)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy of Paliperidone Palmitate Injection in replacing oral antipsychotics for the treatment of schizophrenia and its impact on social function

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-11.

Trial Details

NCT Number	NCT07075237
Lead Sponsor	Jiangsu Province Nanjing Brain Hospital
Conditions	Schizophrenia
Enrollment	120 participants
Start Date	2025-10
Primary Completion	2026-10 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2025-09-29